Supplement for dialysis patients
AssigneeThe Johns Hopkins University
InventorMackenzie Walser
Life of this patent
Estimating the term…
Abstract
Use of a tablet diet supplement for administration to a dialysis patient comprising a mixture of L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-threonine, L-tryptophan, L-tyrosine and L-valine, for preventing and/or correcting hypoalbuminemia in a patient on dialysis.
Claims2
A method of correcting hypoalbuminemia in a patient on hemodialysis which comprises orally administering to the patient an effective amount of a composition comprising a mixture of L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-threonine, L-tryptophan, L-tyrosine and L-valine and continuing said administration to increase serum albumin concentration.
Dependencies are inferred from the claim text.